New therapeutic agents for diabetic kidney disease

Author： Agrawal Varun   Kizilbash Sani Haider   McCullough Peter A  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.5, Iss.4, 2008-07, pp. : 553-575

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

THE ROLE OF ALDOSTERONE ANTAGONISM AGENTS IN DIABETIC KIDNEY DISEASE

By  

JOURNAL OF RENAL CARE, Vol. 41, Iss. 1, 2015-03 ,pp. : 9-18

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biomarkers in diabetic kidney disease

By Buddineni Jaya P   Chaudhary Kunal   Whaley-Connell Adam  

Therapy, Vol. 8, Iss. 2, 2011-03 ,pp. : 121-127

Future Medicine

Access to resources Recommend Favorite

Diabetic Kidney Disease: Act Now or Pay Later

By  

Nephron Clin Pract, Vol. 114, Iss. 3, 2010-02 ,pp. : I-IV

Karger

Access to resources Recommend Favorite

Obesity and chronic kidney disease: therapeutic implications

By Karuparthi Poorna R   Yerram Preethi   Saab Georges   McFarlane Samy I   Whaley-Connell Adam  

Therapy, Vol. 4, Iss. 5, 2007-09 ,pp. : 585-595

Future Medicine

Access to resources Recommend Favorite

Therapeutic Advances in the Treatment of Polycystic Kidney Disease

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 297-302

Karger

Access to resources Recommend Favorite